共 50 条
Dual-Drug Conjugated Glyco-Nanoassemblies for Tumor-Triggered Targeting and Synergistic Cancer Therapy
被引:8
作者:
Katmerlikaya, Tugba Gencoglu
[1
]
Dag, Aydan
[5
]
Ozgen, Pinar Sinem Omurtag
[2
,3
]
Ersen, Busra Cetin
[4
]
机构:
[1] Bezmialem Vakif Univ, Inst Hlth Sci, Dept Biotechnol, TR-34093 Istanbul, Turkey
[2] Istanbul Medipol Univ, Sch Pharm, Dept Analyt Chem, TR-34810 Istanbul, Turkey
[3] Marmara Univ, Fac Pharm, Dept Basic Pharm Sci, TR-34854 Istanbul, Turkey
[4] Ankara Haci Bayram Veli Univ, Inst Grad Studies, Dept Chem, TR-06900 Ankara, Turkey
[5] Bezmialem Vakif Univ, Fac Pharm & Pharmaceut Applicat & Res Ctr, Dept Pharmaceut Chem, TR-34093 Istanbul, Turkey
关键词:
glyco-nanoassemblies;
gemcitabine;
cisPt;
cellular uptake;
synergistic chemotherapy;
GEMCITABINE;
DELIVERY;
D O I:
10.1021/acsabm.2c00749
中图分类号:
TB3 [工程材料学];
学科分类号:
0805 ;
080502 ;
摘要:
Drug-conjugated nanoassemblies potentiate the efficiency of anticancer drugs through the advantages of high drug-loading capacity and passive/active targeting ability in cancer therapy. This study describes the synthesis of gemcitabine (Gem) and cisplatin (cisPt) dual-drug-functionalized glyco-nanoassemblies (GNs) for anticancer drug delivery systems. It also investigates the pH-triggered drug delivery of the conventional anticancer drug cisPt. A Gem-functionalized well-defined glycoblock copolymer backbone (P(iprFruMA-b-MAc)-Gem), which consists of fructose and methacrylic acid segments, was synthesized via a reversible addition-fragmentation chain transfer (RAFT) polymerization method. Following the hydrolysis of the protecting groups on the backbone copolymer, cisPt functionalization of P(FruMA-b-MAc)-Gem in aqueous media was carried out during the transformation of glycoblock polymers into self-assembled spherical glyco-nanoassemblies (GN3). Monodrug-functionalized glyco-nanoassemblies were also prepared either with Gem (GN1) or cisPt (GN2) to compare the synergetic effect of dual-drug conjugated glyco-nanoassemblies (GN3). The sizes of glyco-nanoassemblies GN1, GN2, and GN3 were found as 5.76 +/- 0.64, 59.80 +/- 0.13, and 53.80 +/- 3.90 nm and dispersity (D) values as 0.476, 0.292, and 0.311 by dynamic light scattering (DLS) measurement, respectively. The in vitro studies revealed that the drug-free glyco-nanoassemblies are biocompatible at concentrations higher than 296 mu g/mL. The drug-conjugated glyco-nanoassemblies (GN1 and GN2) exhibited in vitro cytotoxicity against human breast cancer cell lines of MDA-MB-231 comparable to free Gem and cisPt, illustrating an efficient drug release into the tumor environment. Additionally, GNs exhibited higher selectivity and preferential cellular internalization in MDA-MB-231 when compared to healthy cell lines of CCD-1079Sk. These dual-drug conjugated GNs can effectively enhance the killing of cancer cells and increase synergistic chemotherapy.
引用
收藏
页码:5356 / 5364
页数:9
相关论文